1. Home
  2. BVS vs CCIX Comparison

BVS vs CCIX Comparison

Compare BVS & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • CCIX
  • Stock Information
  • Founded
  • BVS 2011
  • CCIX 2023
  • Country
  • BVS United States
  • CCIX United States
  • Employees
  • BVS N/A
  • CCIX N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CCIX
  • Sector
  • BVS Health Care
  • CCIX
  • Exchange
  • BVS Nasdaq
  • CCIX Nasdaq
  • Market Cap
  • BVS 496.7M
  • CCIX 406.0M
  • IPO Year
  • BVS 2021
  • CCIX 2024
  • Fundamental
  • Price
  • BVS $6.68
  • CCIX $11.14
  • Analyst Decision
  • BVS Strong Buy
  • CCIX
  • Analyst Count
  • BVS 4
  • CCIX 0
  • Target Price
  • BVS $15.00
  • CCIX N/A
  • AVG Volume (30 Days)
  • BVS 445.3K
  • CCIX 109.0K
  • Earning Date
  • BVS 05-06-2025
  • CCIX 01-01-0001
  • Dividend Yield
  • BVS N/A
  • CCIX N/A
  • EPS Growth
  • BVS N/A
  • CCIX N/A
  • EPS
  • BVS N/A
  • CCIX 0.33
  • Revenue
  • BVS $567,699,000.00
  • CCIX N/A
  • Revenue This Year
  • BVS N/A
  • CCIX N/A
  • Revenue Next Year
  • BVS $6.09
  • CCIX N/A
  • P/E Ratio
  • BVS N/A
  • CCIX $33.33
  • Revenue Growth
  • BVS 8.60
  • CCIX N/A
  • 52 Week Low
  • BVS $4.51
  • CCIX $10.00
  • 52 Week High
  • BVS $14.38
  • CCIX $11.40
  • Technical
  • Relative Strength Index (RSI)
  • BVS 35.26
  • CCIX N/A
  • Support Level
  • BVS $6.02
  • CCIX N/A
  • Resistance Level
  • BVS $7.07
  • CCIX N/A
  • Average True Range (ATR)
  • BVS 0.39
  • CCIX 0.00
  • MACD
  • BVS -0.02
  • CCIX 0.00
  • Stochastic Oscillator
  • BVS 33.67
  • CCIX 0.00

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About CCIX Churchill Capital Corp IX Ordinary Shares

Churchill Capital Corp IX is a blank check company.

Share on Social Networks: